Evoq Remedies Ltd
₹ 2.96
1.72%
17 Apr
- close price
About
Incorporated in 2010, EVOQ Remedies
Ltd is engaged in the trading of pharmaceuticals formulation and allied products[1]
Key Points
- Market Cap ₹ 7.37 Cr.
- Current Price ₹ 2.96
- High / Low ₹ 12.3 / 2.11
- Stock P/E 81.9
- Book Value ₹ 17.9
- Dividend Yield 0.00 %
- ROCE 0.44 %
- ROE 0.36 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.17 times its book value
- Debtor days have improved from 173 to 54.0 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 5.33% over past five years.
- Promoter holding is low: 11.2%
- Company has a low return on equity of 2.91% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 3.25 | 9.07 | 10.02 | 16.78 | 20.39 | 4.05 | 11.76 | |
| 3.23 | 9.07 | 9.07 | 15.32 | 24.12 | 5.69 | 13.99 | |
| Operating Profit | 0.02 | -0.00 | 0.95 | 1.46 | -3.73 | -1.64 | -2.23 |
| OPM % | 0.62% | -0.00% | 9.48% | 8.70% | -18.29% | -40.49% | -18.96% |
| -0.00 | -0.00 | -0.00 | -0.00 | 6.02 | 2.26 | 2.41 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 | 0.05 |
| Profit before tax | 0.02 | -0.00 | 0.95 | 1.46 | 2.29 | 0.61 | 0.13 |
| Tax % | -0.00% | 25.26% | 25.34% | 29.26% | 26.23% | 30.77% | |
| 0.01 | -0.00 | 0.72 | 1.09 | 1.62 | 0.45 | 0.09 | |
| EPS in Rs | 10.00 | -0.00 | 720.00 | 0.80 | 1.19 | 0.33 | 0.04 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | -11% |
| TTM: | 190% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -56% |
| TTM: | -80% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -44% |
| 1 Year: | -72% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 3% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 13.60 | 13.60 | 13.60 | 24.90 |
| Reserves | 0.01 | 0.01 | 0.73 | 9.57 | 11.19 | 11.64 | 19.64 |
| -0.00 | 0.01 | -0.00 | 8.16 | 9.58 | 4.24 | -0.00 | |
| 2.12 | 5.62 | 7.30 | 2.00 | 0.53 | 7.39 | 5.47 | |
| Total Liabilities | 2.14 | 5.65 | 8.04 | 33.33 | 34.90 | 36.87 | 50.01 |
| -0.00 | -0.00 | -0.00 | -0.00 | 0.01 | 0.01 | 0.22 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 2.14 | 5.65 | 8.04 | 33.33 | 34.89 | 36.86 | 49.79 | |
| Total Assets | 2.14 | 5.65 | 8.04 | 33.33 | 34.90 | 36.87 | 50.01 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.01 | -0.02 | 0.03 | -26.43 | -4.35 | 5.32 | -14.62 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.26 | |
| -0.00 | -0.00 | -0.00 | 29.49 | 1.42 | -5.34 | 14.97 | |
| Net Cash Flow | 0.01 | -0.02 | 0.03 | 3.06 | -2.94 | -0.03 | 0.09 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 138.14 | 189.94 | 249.16 | 552.50 | 308.25 | 156.81 | |
| Inventory Days | 3.39 | 2.42 | 6.97 | 20.66 | 38.33 | 732.34 | |
| Days Payable | 239.57 | 226.66 | 315.25 | 32.05 | -10.20 | 767.44 | |
| Cash Conversion Cycle | -98.04 | -34.30 | -59.11 | 541.11 | 356.78 | 121.72 | |
| Working Capital Days | 1.12 | 1.21 | 26.23 | 614.06 | 612.39 | 2,645.12 | |
| ROCE % | -0.00% | 246.75% | 9.11% | 6.97% | 1.91% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Apr - Submission of certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st March, 2025
-
Board Meeting Intimation for Calling Of Board Meeting On Friday, 18Th April, 2025 At 03:00 P.M.,
10 Apr - Approval of equity shares issuance and fund raising.
-
Submission Of Results For The Half Year And Year Ended On 31St March 2025
10 Apr - Approval of equity shares and raising funds of Rs. 99 Crores.
-
Integrated Filing (Financial)
10 Apr - Integrated filing of financial results for FY 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday, 10Th April, 2025
10 Apr - Approval of equity shares issuance and fund raising.
Business Overview:[1][2]
Company is in the business of marketing, trading, and distribution of a wide range of pharmaceutical formulation products. Apart from this, the company also deals in trading of active pharmaceutical ingredients, Nutraceutical, Ayurvedic, and Herbal Products